• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于TCGA数据,A激酶锚定蛋白5低表达预示非黏液性胃腺癌预后不良。

Low expression of A-kinase anchor protein 5 predicts poor prognosis in non-mucin producing stomach adenocarcinoma based on TCGA data.

作者信息

Zhong Zishao, Ye Zhenhao, He Guihua, Zhang Wang, Wang Jing, Huang Suiping

机构信息

Gastroenterology Department, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China.

Gastroenterology Department, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China.

出版信息

Ann Transl Med. 2020 Feb;8(4):115. doi: 10.21037/atm.2019.12.98.

DOI:10.21037/atm.2019.12.98
PMID:32175408
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7049022/
Abstract

BACKGROUND

In the past, there were not a lot of studies on how A-kinase anchor protein 5 (AKAP5) involving in the pathogenesis and prognosis of non-mucin producing stomach adenocarcinoma (NMSA). Therefore, we studied the relationship between AKAP5 and the prognosis of NMSA and its possible mechanisms using publicly available data from The Cancer Genome Atlas (TCGA).

METHODS

RNA high-throughput sequencing and clinicopathologic data of NMSA were downloaded from the TCGA. Clinical pathologic features associated with AKAP5 expression were analyzed using the chi-square and Fisher exact tests. The relationship between the overall survival (OS) and AKAP5 expression was analyzed by the Kaplan-Meier method and the Cox regression analysis. GSEA analysis was performed using the TCGA dataset.

RESULTS

Our results indicated that the AKAP5 expression was increased in NMSA (all tumor . adjacent mucosa). Also, histologic grade, clinical stage, N classification, and survival status were significantly correlated with AKAP5 expression. Kaplan-Meier curves showed that low AKAP5 expression was associated with a poor OS among the NMSA patients (P=5.003e-05), and in the clinical stage III and IV (P=4.646e-05), TNM stage T3 (P=0.016), T4 (P=0.001), N2 (P=0.012), N3 (P=0.003), M0 (P=3.911e-05), and histological grade G3 (P=1.658e-04) subgroups. Cox regression analysis showed that reduced AKAP5 expression in NMSA is associated with age (HR =1.03, P=0.007), stage (HR =1.84 for stage I, II . stage III, IV, P=0.002) and M classification (HR =1.8 for M0 . M1, P=0.010). Gene sets related to cholesterol homeostasis, glycolysis, estrogen response late, adipogenesis, estrogen response early, notch signaling, and peroxisome were differentially enriched with the low AKAP5 expression phenotype.

CONCLUSIONS

Low expression of AKAP5 may be a potential molecular marker for predicting poor prognosis of NMSA. Besides, cholesterol homeostasis, glycolysis, estrogen response, adipogenesis, notch signaling, and peroxisome may be the key pathways regulated by AKAP5 in NMSA. It also suggested that AKAP5 might potentially have biological functions in the development of stomach adenocarcinoma.

摘要

背景

过去,关于A激酶锚定蛋白5(AKAP5)如何参与非黏液性胃腺癌(NMSA)的发病机制和预后的研究并不多。因此,我们利用来自癌症基因组图谱(TCGA)的公开可用数据,研究了AKAP5与NMSA预后之间的关系及其可能机制。

方法

从TCGA下载NMSA的RNA高通量测序和临床病理数据。使用卡方检验和Fisher精确检验分析与AKAP5表达相关的临床病理特征。采用Kaplan-Meier法和Cox回归分析分析总生存期(OS)与AKAP5表达之间的关系。使用TCGA数据集进行基因集富集分析(GSEA)。

结果

我们的结果表明,NMSA中AKAP5表达增加(所有肿瘤.相邻黏膜)。此外,组织学分级、临床分期、N分类和生存状态与AKAP5表达显著相关。Kaplan-Meier曲线显示,NMSA患者中低AKAP5表达与较差的OS相关(P = 5.003e-05),在临床III期和IV期(P = 4.646e-05)、TNM分期T3(P = 0.016)、T4(P = 0.001)、N2(P = 0.012)、N3(P = 0.003)、M0(P = 3.911e-05)和组织学分级G3(P = 1.658e-04)亚组中也是如此。Cox回归分析表明,NMSA中AKAP5表达降低与年龄(HR = 1.03,P = 0.007)、分期(I、II期与III、IV期相比,HR = 1.84,P = 0.002)和M分类(M0与M1相比,HR = 1.8,P = 0.010)有关。与胆固醇稳态、糖酵解、雌激素晚期反应、脂肪生成、雌激素早期反应、Notch信号和过氧化物酶体相关的基因集在低AKAP5表达表型中差异富集。

结论

AKAP5低表达可能是预测NMSA预后不良的潜在分子标志物。此外,胆固醇稳态、糖酵解、雌激素反应、脂肪生成、Notch信号和过氧化物酶体可能是AKAP5在NMSA中调控的关键途径。这也表明AKAP5在胃腺癌的发生发展中可能具有生物学功能。

相似文献

1
Low expression of A-kinase anchor protein 5 predicts poor prognosis in non-mucin producing stomach adenocarcinoma based on TCGA data.基于TCGA数据,A激酶锚定蛋白5低表达预示非黏液性胃腺癌预后不良。
Ann Transl Med. 2020 Feb;8(4):115. doi: 10.21037/atm.2019.12.98.
2
Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data.TFAP2B 在子宫内膜癌中表达降低预示不良预后:基于 TCGA 数据的研究。
Gynecol Oncol. 2018 Jun;149(3):592-597. doi: 10.1016/j.ygyno.2018.03.057. Epub 2018 Mar 28.
3
CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.CCDC68预测结直肠癌患者预后不良:一项基于TCGA数据的研究
J Gastrointest Oncol. 2022 Apr;13(2):657-671. doi: 10.21037/jgo-22-148.
4
Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.基于 TCGA 和 GEO 数据集构建与胃腺癌早期差异表达基因相关的 mRNA 预后特征。
Eur J Med Res. 2022 Oct 17;27(1):205. doi: 10.1186/s40001-022-00827-4.
5
CDCA8 as an independent predictor for a poor prognosis in liver cancer.CDCA8作为肝癌预后不良的独立预测指标。
Cancer Cell Int. 2021 Mar 8;21(1):159. doi: 10.1186/s12935-021-01850-x.
6
MiR-3614-5p Is a Potential Novel Biomarker for Colorectal Cancer.MiR-3614-5p是一种潜在的新型结直肠癌生物标志物。
Front Genet. 2021 May 28;12:666833. doi: 10.3389/fgene.2021.666833. eCollection 2021.
7
[Increased expression of SEMA5B in gastric adenocarcinoma predicts poor prognosis: a study based on TCGA data].[SEMA5B在胃腺癌中表达增加预示预后不良:基于TCGA数据的研究]
Zhonghua Zhong Liu Za Zhi. 2021 Aug 23;43(8):856-860. doi: 10.3760/cma.j.cn112152-20200104-00005.
8
Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis.胃癌中DGKI的过表达预示预后不良。
Front Med (Lausanne). 2020 Jul 7;7:320. doi: 10.3389/fmed.2020.00320. eCollection 2020.
9
LUM Expression and Its Prognostic Significance in Gastric Cancer.LUM在胃癌中的表达及其预后意义
Front Oncol. 2020 May 15;10:605. doi: 10.3389/fonc.2020.00605. eCollection 2020.
10
Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data.基于 TCGA 数据,E2F2 的增加预示着 HCC 患者预后不良。
BMC Cancer. 2020 Oct 28;20(1):1037. doi: 10.1186/s12885-020-07529-2.

引用本文的文献

1
expression in stomach adenocarcinoma and its preliminary role in predicting immunotherapy response.在胃腺癌中的表达及其在预测免疫治疗反应中的初步作用。
Front Immunol. 2025 May 5;16:1578068. doi: 10.3389/fimmu.2025.1578068. eCollection 2025.
2
Development and validation of a risk prognostic model based on the infection phenotype for stomach adenocarcinoma.基于胃腺癌感染表型的风险预后模型的开发与验证
Heliyon. 2024 Aug 24;10(17):e36882. doi: 10.1016/j.heliyon.2024.e36882. eCollection 2024 Sep 15.
3
Immune activity score to assess the prognosis, immunotherapy and chemotherapy response in gastric cancer and experimental validation.免疫活性评分用于评估胃癌的预后、免疫治疗和化疗反应及其实验验证。
PeerJ. 2023 Nov 14;11:e16317. doi: 10.7717/peerj.16317. eCollection 2023.
4
Use of machine learning-based integration to develop an immune-related signature for improving prognosis in patients with gastric cancer.基于机器学习的整合用于开发免疫相关特征,以改善胃癌患者的预后。
Sci Rep. 2023 Apr 29;13(1):7019. doi: 10.1038/s41598-023-34291-9.
5
Identification of a Metabolic Reprogramming-Associated Risk Model Related to Prognosis, Immune Microenvironment, and Immunotherapy of Stomach Adenocarcinoma.鉴定与胃腺癌预后、免疫微环境及免疫治疗相关的代谢重编程风险模型
J Oncol. 2022 Sep 21;2022:7248572. doi: 10.1155/2022/7248572. eCollection 2022.
6
The Association between TRP Channels Expression and Clinicopathological Characteristics of Patients with Pancreatic Adenocarcinoma.TRP 通道表达与胰腺导管腺癌患者临床病理特征的关系。
Int J Mol Sci. 2022 Aug 12;23(16):9045. doi: 10.3390/ijms23169045.
7
Cancer Cell Acid Adaptation Gene Expression Response Is Correlated to Tumor-Specific Tissue Expression Profiles and Patient Survival.癌细胞酸适应性基因表达反应与肿瘤特异性组织表达谱及患者生存率相关。
Cancers (Basel). 2020 Aug 5;12(8):2183. doi: 10.3390/cancers12082183.

本文引用的文献

1
The necessity of adjuvant radiotherapy for locally advanced gastric cancer in China.中国局部晚期胃癌辅助放疗的必要性。
Transl Cancer Res. 2019 Apr;8(2):676-682. doi: 10.21037/tcr.2019.03.11.
2
Inpatient burden of gastric cancer in the United States.美国胃癌的住院负担。
Ann Transl Med. 2019 Dec;7(23):772. doi: 10.21037/atm.2019.11.54.
3
Gastric cancer surgery: historical background and perspective in Western countries versus Japan.胃癌手术:西方国家与日本的历史背景及展望
Ann Transl Med. 2019 Sep;7(18):493. doi: 10.21037/atm.2019.08.48.
4
Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation.Notch 和 mTOR 信号通路促进人胃癌细胞增殖。
Neoplasia. 2019 Jul;21(7):702-712. doi: 10.1016/j.neo.2019.05.002. Epub 2019 May 24.
5
Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review.代谢重编程导致胃癌中糖酵解异常:综述
Onco Targets Ther. 2019 Feb 13;12:1195-1204. doi: 10.2147/OTT.S189687. eCollection 2019.
6
Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs).原发性乳腺癌及其配对转移病灶的外显子组测序揭示了 A-激酶锚定蛋白家族(AKAPs)中富含转移的突变。
BMC Cancer. 2018 Feb 12;18(1):174. doi: 10.1186/s12885-018-4021-6.
7
CaMKII regulates the depalmitoylation and synaptic removal of the scaffold protein AKAP79/150 to mediate structural long-term depression.钙调蛋白依赖性蛋白激酶 II 调节支架蛋白 AKAP79/150 的去棕榈酰化和突触去除,从而介导结构长时程抑制。
J Biol Chem. 2018 Feb 2;293(5):1551-1567. doi: 10.1074/jbc.M117.813808. Epub 2017 Dec 1.
8
Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer.靶向丙酮酸脱氢酶复合物/丙酮酸脱氢酶激酶(PDC/PDK)轴治疗癌症。
J Natl Cancer Inst. 2017 Nov 1;109(11). doi: 10.1093/jnci/djx071.
9
deficiency promotes GC invasion and migration via the enhancements of LDHA expression and aerobic glycolysis.缺乏会通过增强 LDHA 表达和有氧糖酵解促进 GC 的侵袭和迁移。
Endocr Relat Cancer. 2017 Nov;24(11):565-578. doi: 10.1530/ERC-17-0058. Epub 2017 Sep 5.
10
Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis.己糖激酶2在消化系统实体瘤中过表达的预后不良:一项荟萃分析
Oncotarget. 2017 May 9;8(19):32332-32344. doi: 10.18632/oncotarget.15974.